Global Biosimilars Market Size Was Valued at USD 34.01 Billion in 2023 and is Projected to Reach USD 143.97 Billion by 2032, Growing at a CAGR of 17.39% From 2024-2032.
Biosimilar is a biological medicinal product also referred to as follow-on biologic or coming entry biologic. It is the same copy of an initial product produced by a diverse company. It is a reliably authorized version of...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian